SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-031771
Filing Date
2016-10-18
Accepted
2016-10-18 06:35:36
Documents
1
Period of Report
2016-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3990
  Complete submission text file 0000899243-16-031771.txt   5298
Mailing Address ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
CAGNONI PABLO J (Reporting) CIK: 0001205703 (see all company filings)

Type: 3 | Act: 34 | File No.: 333-213577 | Film No.: 161939804

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
SIC: 2836 Biological Products, (No Diagnostic Substances)